NCT00742105 Phase I Study to Determine the Maximum Tolerate Dose (MTD) of BGT226 in Advanced Solid Tumors in Japan Status TERMINATED Phase PHASE1
NCT00740571 Amitriptyline or Pregabalin to Treat Neuropathic Pain in Incurable Cancer Status UNKNOWN Phase PHASE3
NCT00739414 Dose-escalating Study of LBH589 in Adult Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00737230 Care of Cancer Patients With Bowel Injury Caused by Radiation Therapy to the Pelvis Status COMPLETED Phase NA
NCT00735111 Do Self-Rated Performance Status Scores Correlate With Health-Care-Provider-Scores? Status COMPLETED Phase NA
NCT00727922 Protective Effect of Mangafodipir Against Oxaliplatin Neurotoxicity Status COMPLETED Phase PHASE2
NCT00726011 Tetrodotoxin Open-label Efficacy and Safety Continuation Study Status COMPLETED Phase PHASE3
NCT00725114 Safety & Efficacy Study of Subcutaneous Tetrodotoxin for Moderate to Severe Inadequately Controlled Cancer-related Pain Status COMPLETED Phase PHASE3
NCT00724100 A Trial of ALB 109564(a) in Subjects With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT00717717 A Clinical Controlled Trial on the Effect of Physical Activity After Cancer Treatment (PACT) Status COMPLETED Phase NA
NCT00716898 Pharmacokinetics of Low Molecular Weight Heparin in Cancer Patients Status COMPLETED Phase N/A
NCT00716872 Improving the Sleep of Cancer Patients Using an Internet-Based Program Status COMPLETED Phase NA
NCT00709813 Study to Test a Computer-assisted Support System to Improve Patient-centered Care and Symptom Relief in Cancer Patients Status COMPLETED Phase NA
NCT00708721 Low-dose Oral Clofarabine for the Treatment of IPSS INT-1, INT-2 or HIGH Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia Status TERMINATED Phase PHASE1/PHASE2